Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49-Reference-Cited by-同舟云学术

Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49

Published:2022-03 Issue:3 Volume:54 Page:324-330
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Pernot Simon^ORCID,Pellerin Olivier,Mineur Laurent,Monterymard Carole,Smith Denis,Lapuyade Bruno,Gallois Claire,Khemissa Akouz Faiza,De Baere Thierry,Tougeron David,Thirot-Bidault Anne,Audemar Franck,Simon Mireille,Lecaille Cedric,Louafi Sami,Lepage Come,Ducreux Michel,Taieb Julien

Funder

Amgen Inc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience;Kennedy;Int J Radiat Oncol Biol Phys,2006

2. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

3. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study;Cremolini;Lancet Oncol,2015

4. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

5. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus;Adam;Oncologist,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy;European Radiology;2024-07-30

2. Evaluating the role of wound‐healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications;International Wound Journal;2024-03

3. Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer.;2024-02-14

4. Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial;European Journal of Cancer;2023-12

5. Exploring a Novel Technique to Tackle the Shortage of Devices for Hepatic Arterial Infusion Chemotherapy: Early Results of an Alternate Approach for Percutaneous Arterial Port Catheter Placement;Cancers;2023-09-26